Molecular Pharmacology (USA), Ltd. (MLPH)

Market Cap	799.64K -40.3%
Revenue (ttm)	n/a
Net Income	-105.18K
EPS	-0.00
Shares Out	999.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	358,340
Average Volume	125,823
Open	0.0008
Previous Close	n/a
Day's Range	0.0008 - 0.0008
52-Week Range	0.0000 - 0.0097
Beta	-0.42
RSI	49.29
Earnings Date	n/a

About MLPH

Molecular Pharmacology (USA), Ltd., a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States. The company, through its subsidiary, Molecular Pharmacology Pty. Ltd., develops analgesic and anti-inflammatory molecule, known as Tripeptofen for the treatment of common every-day pain. Its products are available in various dosage forms, formulations, line extensions, and package configurations. The company focuses on marketing its products through pharmaceutical di...

• Industry: Shell Companies
• Sector: Financials
• CEO: Jeffrey Edwards
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: MLPH